FSH beta mutants that are glycosilated at residues N55 and T57
US7700112B2 · kind B2 · utility
1Cited by
13References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2004 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | Jun 7, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A novel FSH mutant with increased glycosylation and longer half-lifes for use in inducing folliculogenesis in human patients is described. The FSH mutant permits the use of lower cumulative doses of FSH to achieve the same or better clinical result.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.